psychedelic therapeutics

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

BHP explores a potential $2 billion sale of Chilean desalination and electricity transmission assets supporting its major copper operations. Representative image.

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone shares surge after Xavier Niel’s Vega agrees to acquire e&’s 16.21 percent stake in a £4.4 billion transaction. Representative image.

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers and Micron Technology expand United States semiconductor supply capacity through a $500 million financing and 10-year silicon wafer agreement. Representative image.

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s new long-range strike command intensifies its campaign against Russian oil refineries, fuel infrastructure and wartime logistics networks. Representative image.

Ukraine’s drone war enters new phase with dedicated command targeting Russia

How Johns Hopkins IRB approval strengthens Clearmind Medicine’s clinical credibility in addiction medicine

Clearmind Medicine’s Johns Hopkins-backed CMND-100 trial expansion could reshape addiction therapeutics. Discover what industry observers are watching next.

bySoujanya Ravi

May 28, 2026

What NPX-5’s Phase IIb trial means for the future of oncology-linked mental health treatments

NPX-5 enters Phase IIb trials for cancer-related mental health. Discover what this means for biotech strategy, regulation, and future treatments.

bySoujanya Ravi

April 25, 2026

The Latest

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s drone war enters new phase with dedicated command targeting Russia

How Johns Hopkins IRB approval strengthens Clearmind Medicine’s clinical credibility in addiction medicine

What NPX-5’s Phase IIb trial means for the future of oncology-linked mental health treatments

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s drone war enters new phase with dedicated command targeting Russia

Victoria PLC (AIM: VCP) holds refinancing rally as £300m debt cut tests flooring recovery

Baltic Power offshore wind farm sends first electricity to Poland’s grid as ORLEN and Northland near completion

SK Hynix (SKHYV) Nasdaq debut raises $26.5bn, second-largest US IPO ever after SpaceX

Almonty Industries (ALM) jumps 11% as DA Davidson lifts PT to $33 on tungsten thesis